Clinical Trial Update: Long-term Investigation of Resveratrol in Obesity [NA]

View source ↗

Summary

A long-term clinical trial evaluating resveratrol in obesity and related metabolic and inflammatory conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Insulin Resistance
• Obesity
• Osteoporosis

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Aarhus | Conditions: Obesity, Inflammation | NA | Status: COMPLETED